WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity
1 other identifier
interventional
20
1 country
1
Brief Summary
This study is to develop, test, and optimize a soft hip wearable robot for individuals who have experience a stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Jul 2025
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2025
CompletedStudy Start
First participant enrolled
July 7, 2025
CompletedFirst Posted
Study publicly available on registry
July 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
August 29, 2025
August 1, 2025
3 years
June 27, 2025
August 22, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
6-minute walk test
Primary outcome for Optimization aim of study.
Baseline (Single-session)
Metabolic Cost
Primary outcome for Optimization aim of study. Data collected using Cosmed K5 Metabolic Unit
Baseline (single session)
Study Arms (1)
Healthy Population
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- \- Be at least 6 months post-stroke, have a diagnosis of Parkinson's, have a diagnosis of multiple sclerosis, or an adult older than 65 with no known neurological diagnoses.
- For the Optimization Aim of the study, Participants may also be healthy individuals with no known impairments.
- Age: 18-89 years of age
- For stroke, Parkinson's, multiple sclerosis, or older adult participants, must have adequate cognitive function (MMSE score \>17)
- Ability to walk at least 10 meters with maximum of 1 person assist
- Able to safely fit into the WIM exosuit, which is confirmed via an in-person fitting..
You may not qualify if:
- \- \<90 days post major orthopedic surgery (i.e. hip, knee, and/or ankle joint replacement.)
- \< 6 months post CABG or cardiac valve procedure
- Any skin irritations / conditions that may preclude a participant from tolerating the use of the exosuit.
- Severe osteoporosis, defined as osteoporosis that has been diagnosed and a participant's doctor has recommended pharmacologic treatment, or there is both a history of osteoporosis and a history of fractures.
- Serious cardiac conditions, such as hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living.
- Pregnancy
- Uncontrolled hypertension (resting systolic blood pressure greater than or equal to 150, or resting diastolic pressure greater than or equal to 90.) If a participant demonstrates a BP greater than these values, then the participant will sit quietly for 5 mins, and then be re-checked. If the BP values remain over those thresholds, then the participant will be excluded. Individuals in such situations may return to be re-screened for participation after they follow up with their physician and the hypertension is better controlled.
- Lower extremity fracture, either currently or within the past 6 months.
- Modified Ashworth Spasticity (MAS) scores of ≥ 3 in hip flexors or extensors, if the participant is post-stroke or multiple sclerosis.
- Pre-existing neurological disorders such as amyotrophic lateral sclerosis (ALS), dementia
- History of major head trauma, lower extremity amputation, non-healing ulcers of a lower extremity, ongoing active infections, legal blindness, or a history of significant psychiatric illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator:Arun Jayaraman, PT, PhD,Shirley Ryan AbilityLab
Study Record Dates
First Submitted
June 27, 2025
First Posted
July 11, 2025
Study Start
July 7, 2025
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
August 29, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share